Excellence in Hemoglobinopathies Research Award Program

by: Michael Saunders

The National Institutes of Health, more commonly known as the NIH, is a federal government agency operating within the United States Department of Health and Human Services that is appropriately responsible for supporting the nation's biomedical and health-related research studies.

The programs and grants of the NIH are specifically tailored to help in the achievement of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

Initially, the NIH and the NHLBI will enter into a five-year cooperative agreement with the most compelling applicant who has submitted a research proposal that could potentially develop therapeutic molecules, biomarkers, or imaging modalities in the field of hemoglobinopathies.

  (continued...)

Excellence in Hemoglobinopathies Research Award Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Health Resources and Services Administration's Licensure Portability Grant Program
The Health Resources and Services Administration has constituted the Licensure Portability Grant Program (LPGP) wherein they aim to improve the experience of State licensing boards that have manifested a credible record in implementing cross-border activities in order to help overcome licensure barriers in the provision of telemedicine services across various States.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---